3 , (II), differ only by a methyl substituent on the seven-membered oxazepine ring in (II). In both compounds, these rings have a twist-chair conformation. The phenyl ring makes a dihedral angle of 73.42 (10) with the benzimidazole ring system mean plane (r.m.s. deviation = 0.015 Å ) in (I) and 83.07 (7) in (II) (r.m.s. deviation = 0.026 Å ). The methyl carboxylate groups are planar to within 0.031 (2) in (I) and 0.003 (2) Å in (II). They are inclined to the phenyl and benzimidazole ring system by 33.78 (16) and 87.56 (14) , respectively, in (I) and by 53.04 (12) and 60.22 (11) , respectively, in (II). In the crystal of (I), molecules stack in a herringbone fashion and are linked by C-HÁ Á ÁO hydrogen bonds, forming chains along [100]. In the crystal of (II), there are no significant intermolecular interactions present.
Chemical context
Fused oxazepinone derivatives have attracted considerable attention owing to their promising biological activities, such as anticancer, anti-HIV, antidepressant and antitumor activities (Liu et al., 2011) . Tumor growth requires the support of an associated blood supply, making tumor vasculature a potential target for anticancer therapy. This principle has inspired decades of research into the pathways of angiogenesis (the formation of new blood vessels), leading to the identification of a family of vascular endothelial growth factors (VEGFs) that stimulate this process (Edwards et al., 2011) . Sevenmembered oxygen heterocycles are ubiquitous in natural products and show a wide spectrum of biological activity (Bera et al., 2014) .
Structural commentary
The molecular structure of compound (I) is illustrated in Fig. 1 . The C1-N1-C13 bond angle is 105.2 (2)
. The seven-ISSN 1600-5368 membered oxazepine ring (O1/N2/C7/C8/C11-C13) has a twist-chair conformation, as can be evidenced by the torsion angles C12-C13-N2-C7 = À3.2 (3) and C8-C11-O1-C12 = À78. 33 (18) . The phenyl ring (C14-C19) is inclined to the benzimidazole ring system [N1/N2/C1-C6/C13; r.m.s. deviation = 0.026 Å ] by 73.42 (10) . The methyl carboxylate group (C9/O2/O3/C10) is planar to within 0.031 (2) Å and is inclined to the phenyl ring and the benzimidazole ring system by 33.78 (16) and 87.56 (14) , respectively. The molecular structure of compound (II) is illustrated in Fig. 2 . The C1-N1-C13 bond angle of 104.27 (15) . The seven-membered oxazepine ring (O1/N2/C7/C8/C11-C13) also has a twist-chair conformation, with torsion angles C12-C13-N2-C7 = À6.6 (3) and C8-C11-O1-C12 = À74. 17 (18) . The principle difference in the two compounds concerns the orientation of the phenyl ring (C15-C20) with respect to the benzimidazole ring system [N1/N2/C1-C6/C13; r.m.s. deviation = 0.026 Å ]. In (II), this angle is 83.07 (17) considerably larger than the same angle in (I), viz 73.42 (10) . Here the methyl carboxylate group (C9/O2/O3/C10), planar to within 0.003 (2) Å , is inclined to the phenyl ring and the benzimidazole ring system by 53.04 (12) and 60.22 (11) , respectively. These angles are also very different to those observed in compound (I), viz 33.78 (16) and 87.56 (14) , respectively.
Supramolecular features
In the crystal of (I), molecules stack in a herringbone fashion and are linked by C-HÁ Á ÁO hydrogen bonds, forming chains along the a-axis direction (Table 1 and Fig. 3 ).
In the crystal of (II), there are no significant intermolecular interactions present.
Database survey
In the Cambridge Structural Database (Version 5.35, last update May 2014; Groom & Allen, 2014) there are a large number of compounds containing an oxazepine-type ring, but only one entry was found for such a ring fused to a benzimidazole unit. This compound, 1H,3H-[1,4][4,3-a]benzimidazole (UQILOW; Zhang et al., 2011) , has an oxazepino ring with a C C bond in the seven-membered ring.
Synthesis and crystallization
A mixture of Z-methyl-2-(bromomethyl)-3-phenylacrylate (1.0 mol) and (1H-benzo[d]imidazole-2-yl)methanol (1.1 mol) for (I), but (1H-benzo[d]imidazole-2-yl)ethanol (1.1 mol) for (II), together with CS 2 CO 3 (1 mol) in CH 3 CN (10 ml) was stirred for 8 h. After completion of the reactions, monitored by TLC, the solvents were evaporated under reduced pressure. The residues were diluted with ethyl acetate then washed with brine and water. The organic layers were separated and the residues were subjected to column chromatography using ethyl acetate and hexane (2:8) as eluent. The products were dissolved in chloroform and heated for 2 min. The resulting solutions were subjected to crystallization by slow evaporation of the solvent for 48 h resulting in the formation of colourless block-like crystals of compounds (I) and (II). The molecular structure of compound (I), with atom labelling. Displacement ellipsoids are drawn at the 30% probability level.
Figure 2
The molecular structure of compound (II), with atom labelling. Displacement ellipsoids are drawn at the 30% probability level. Table 1 Hydrogen-bond geometry (Å , ) for (I). Table 1 for details).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . In both compunds, the C-bound H atoms were positioned geometrically and allowed to ride on their parent atoms: C-H = 0.93-0.98 Å with U iso (H) = .2U eq (C) or 1.5U eq (Cmethyl). 
